Evotec SE (EVO) stock
EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.32−0.13 (-8.97%)
Close on Nov 20, 2026Market cap $469.34MP/E –Yield –
Evotec shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 178M, up 0.2% from the year before. The highest annual figure on record is 178M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 178M | +0.2% |
| FY2024 | Dec 31, 2024 | 177M | +0.2% |
| FY2023 | Dec 31, 2023 | 177M | +0.1% |
| FY2022 | Dec 31, 2022 | 177M | +6.2% |
| FY2021 | Dec 31, 2021 | 166M | +8.2% |
| FY2020 | Dec 31, 2020 | 154M | +2.7% |
| FY2019 | Dec 31, 2019 | 150M | – |
See a number that looks wrong?